Direct supply from state-of-the-art manufacturing facilities with comprehensive analytical support.
Technical Analysis of Moxonidine (CAS 75438-57-2) Synthesis, Central Sympatholytic Action, and Global Manufacturing Benchmarks.
Moxonidine is a potent, second-generation central antihypertensive agent with high selectivity for the imidazoline $I_1$ receptor over $\alpha_2$-adrenergic receptors. Unlike legacy sympatholytic drugs such as clonidine, Moxonidine significantly lowers central sympathetic tone without inducing severe sedation or xerostomia. As a premier China Moxonidine Supplier & Factory, our industrial infrastructure combines advanced synthetic chemistry, automated process analytical technology (PAT), and rigorous compliance with international cGMP standards (FDA, EMA, NMPA) to secure continuous supply chains for global pharmaceutical companies.
Moxonidine exhibits a 40:1 binding preference for $I_1$-imidazoline receptors relative to $\alpha_2$-adrenoceptors located in the rostral ventrolateral medulla. This selective target engagement leads to a substantial reduction in systemic vascular resistance (SVR) while retaining normal reflex baroreceptor control.
Clinical studies demonstrate that long-term therapy with Moxonidine improves insulin sensitivity and glucose uptake in hypertensive patients suffering from metabolic syndrome or type 2 diabetes. Chemical batch control ensures zero heavy metal contamination affecting bio-distribution.
Formulated as 4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methylpyrimidin-5-amine (CAS 75438-57-2), our API demonstrates exceptional chemical stability across ICH Accelerated Stability testing protocols ($40^\circ\text{C} \pm 2^\circ\text{C} / 75\% \text{ RH} \pm 5\% \text{ RH}$).
Full control over reaction kinetics, crystallization kinetics, and impurity isolation under cGMP guidelines.
The industrial synthesis of Moxonidine requires precise execution of multi-step nucleophilic pyrimidine substitutions followed by controlled imidazoline ring coupling. Our facility utilizes closed-loop reactor trains to maintain batch consistency and minimize oxidative byproduct formation.
| Analytical Test Parameter | Acceptance Criteria (EP / USP Specs) | Gentolex Batch Standard | Testing Methodology |
|---|---|---|---|
| Appearance | White to almost white crystalline powder | Off-white to white microcrystalline powder | Visual Inspection |
| Assay (Dried Basis) | 98.0% – 102.0% | 99.85% (Average across batches) | RP-HPLC vs. Reference Standard |
| Related Substances (Impurity A, B, C) | Individual ≤ 0.10%, Total ≤ 0.50% | Individual ≤ 0.03%, Total ≤ 0.12% | High-Performance Liquid Chromatography (UV at 230nm) |
| Residual Solvents | Methanol < 3000 ppm, Toluene < 890 ppm | Methanol < 200 ppm, Toluene < 50 ppm | Headspace Gas Chromatography (GC-FID) |
| Particle Size Distribution | Customizable ($D_{90} < 20\,\mu\text{m}$ available) | $D_{50} < 5\,\mu\text{m}, D_{90} < 12\,\mu\text{m}$ (Micronized) | Laser Diffraction (Malvern Mastersizer 3000) |
| Heavy Metals / Elemental Impurities | Meets ICH Q3D limits for oral dosage forms | Lead, Cadmium, Arsenic, Mercury < 1 ppm | Inductively Coupled Plasma Mass Spectrometry (ICP-MS) |
Our analytical R&D team has fully synthesized and characterized all known process-related impurities, including 4-chloro-6-methoxy-2-methylpyrimidin-5-amine and hydroxy-substituted intermediates. Chromatographic methods guarantee Baseline separation ($R_s > 2.0$) for critical pairs, assuring non-infringing toxicity profiles.
Through state-of-the-art fluid bed micronization and controlled anti-solvent crystallization, we offer optimized particle size distributions (PSD) designed to enhance dissolution rates in immediate-release oral solid doses (OSD). Polymorph Form I stability is rigorously confirmed via Powder X-Ray Diffraction (PXRD).
State-of-the-art continuous flow manufacturing integrated with green chemistry principles.
Our 250,000 m² facility is operated via centralized Distributed Control Systems (DCS) and SCADA architecture. Real-time temperature, pH, pressure, and dosing parameters prevent process deviations and guarantee absolute batch reproducibility.
We maintain direct synthesis pipelines for key starting materials (KSMs), mitigating geopolitical and market fluctuations. Backward integration guarantees uninterrupted raw material availability and lower cost-of-goods (COGS) for partner formulation hubs.
Equipped with thermal oxidizers (RTO), Advanced Oxidation Process (AOP) wastewater handling, and solvent recovery columns, our eco-friendly chemical plant operates under zero-discharge compliance regulations, protecting global supply longevity.
Connecting the world with premium chemical services, active pharmaceutical ingredients, and customized peptide synthesis.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
An overall factory construction area of 250,000 square meters under international standard allows us to offer flexible, scalable, and cost-effective solutions for clients globally. Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
Custom route synthesis, process optimization, and structural characterization using advanced nuclear magnetic resonance (NMR) and mass spectrometry.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
Comprehensive regulatory filings, regional localization, and flexible commercial contract models.
We provide complete CTD Dossier Module 3 datasets for seamless registration. DMF filing packages, CEP certificates, Stability Data (Zone II & IVb), and Validation Protocol documents are instantly accessible for customer submission.
With dedicated market representatives in Mexico, South Africa, Europe, and LATAM, we deliver rapid customs clearance, local duty management, warehouse distribution, and localized technical assistance.
Available in flexible packaging formats ranging from 1kg trial batches in aluminum foil bags to 25kg double PE-lined fiber drums. Temperature-controlled cold chain air freight and ambient ocean shipping options provided.
Trusted by world-class generic manufacturers, research institutes, and biopharmaceutical enterprises.
Stay informed with current technical developments across peptide synthesis, therapeutic APIs, and global chemical manufacturing.
Introduction to Selank Acetate API: Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient (API) composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Originally developed through neuropharmacological research, Selank is a derivative of the endogenous...
View Details
Trusted Thymosin Beta-4 API Manufacturer and Global Peptide Supplier As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies, pharmaceutical research organizations, and li...
View Details
Introduction BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair, gastrointestinal protection, angiogenesis, and inflammatory regulation. As a peptide ac...
View Details
With the continuous development of neuroscience, peptide technology, and life science research, neuroactive peptides have become an important area of scientific investigation. Semax, a synthetic peptide derived from an ACTH fragment, has attracted attention among researchers due to its unique mol...
View Details
SS-31 (Elamipretide) API SS-31 API, also known as Elamipretide, MTP-131, Bendavia, and SS31, is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane. By stabilizing mitochondrial structure and supporting cellular bioenergetics, SS-31 ha...
View DetailsEssential technical, commercial, and regulatory guidance for pharmaceutical sourcing managers and QA teams.
Our commercial batches consistently achieve ≥99.8% HPLC assay purity. Individual impurities are guaranteed below 0.05%, fully complying with European Pharmacopoeia (EP) and United States Pharmacopeia (USP) monographs.
We provide comprehensive Type II Drug Master Files (USDMF) for US FDA submissions, CEP/COS documentation for European authorities, as well as full CTD Dossier Module 3 structures for global health agency registrations.
Yes. We specialize in particle size engineering and can supply custom micronized powder with $D_{90} < 10\,\mu\text{m}$ or $D_{50} < 5\,\mu\text{m}$, optimized for uniform content distribution in low-dose oral OSD tablets (0.2mg, 0.3mg, and 0.4mg).
We support R&D evaluation with sample packs ranging from 10g to 500g accompanied by full Certificates of Analysis (COA), NMR, IR, and HPLC spectra. Commercial MOQs start at 1 kg with global delivery within 5-7 business days via qualified courier.
We welcome both physical on-site audits and remote video audits by QA teams. Our cGMP-compliant facilities hold active ISO9001, ISO14001, and local NMPA GMP certifications.
Explore our specialized portfolio of custom peptides, niche chemicals, and API raw materials.
